Results 61 to 70 of about 93,056 (192)

Peripartum cardiomyopathy: Clinical, hemodynamic, histologic and prognostic characteristics [PDF]

open access: yes, 1986
Peripartum cardiomyopathy is defined as left ventricular dilation and failure, first developing during the third trimester of pregnancy or in the first 6 months postpartum.
O’Connell, John B.   +6 more
core   +1 more source

The Epidemiology of Pulmonary Hypertension in Sub‐Saharan Africa—A Systematic Report

open access: yesPulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Noncommunicable diseases (NCDs) are on the rise in sub‐Saharan Africa (SSA), with cardiovascular NCD accounting for most deaths. Pulmonary hypertension (PH) is a highly morbid NCD; however, contemporary prevalence data are lacking. We performed a systematic literature search of all echocardiographic or right heart catheterization studies ...
Katarina Zeder   +13 more
wiley   +1 more source

Can peripartum cardiomyopathy be familial?

open access: yes, 2009
Published in "International Journal of Cardiology" vol.137, n°2(Letter to the Editor) Peripartum cardiomyopathy (PPCM) is a rare disorder, with four principal features: 1--development of cardiac heart failure in the last month of pregnancy or within five
Baruteau, Alban-Elouen   +5 more
core   +1 more source

Cangrelor Bridge for Repeat Cesarean After Third Trimester Percutaneous Coronary Intervention for Total Occlusion NSTEMI

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
Visual Summary, case timeline of non‐ST‐elevation MI with PCI followed by cangrelor bridge for classical cesarean delivery. ABSTRACT Acute coronary syndrome is an uncommon but potentially life‐threatening complication in pregnancy, and dual antiplatelet therapy presents challenges in patients requiring cesarean delivery.
Vidya N. Mullangi   +8 more
wiley   +1 more source

Intravenous immune globulin in the therapy of peripartum cardiomyopathy [PDF]

open access: yes, 1999
OBJECTIVESWe sought to evaluate the effect of therapy with intravenous immune globulin on recovery of left ventricular function in women presenting with peripartum cardiomyopathy.BACKGROUNDPeripartum cardiomyopathy is a rare complication of pregnancy ...
Warren D Rosenblum   +19 more
core   +1 more source

Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report

open access: yesJA Clinical Reports, 2019
Background Peripartum cardiomyopathy is an uncommon form of heart failure that occurs in otherwise healthy women during pregnancy or until 5 months postpartum.
Saya Hakata   +8 more
doaj   +1 more source

Peripartum takotsubo cardiomyopathy after an emergency Caesarean delivery—diagnosis and specialist management

open access: yesBJA Open
We report the case of a 32-yr-old primiparous patient who underwent an emergency Caesarean delivery and subsequently developed peripartum takotsubo cardiomyopathy necessitating transfer to a tertiary referral critical care unit and the heart failure ...
Cathriona Murphy   +3 more
doaj   +1 more source

Peripartum cardiomyopathy (clinical case)

open access: yesСеченовский вестник, 2020
Introduction. Peripartum cardiomyopathy (PPKMP) is a rare cause of heart failure (CHF) in healthy women during pregnancy and within 5 months after delivery.Case report.
Yu. V. Ilina   +3 more
doaj   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Genotype–Phenotype Discordance in Cardiomyopathies: Pathophysiology, Clinical Expression, and Therapeutic Considerations

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Cardiomyopathies encompass a spectrum of myocardial disorders often attributed to underlying genetic mutations. However, genotype–phenotype discordance where the genetic profile does not align with the expected clinical presentation poses significant diagnostic, prognostic, and therapeutic challenges.
Abubakar Nazir   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy